Intervention

Vinblastine

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting0

Common conditions16

Lead sponsors shown5

Clinical trials

7 shown

Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)NCT05008224 · 2021-10-07

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin LymphomaNCT01771107 · 2013-03-08

Prospective Study on HIV-related Hodgkin LymphomaNCT01468740 · 2004-03-01

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate CancerNCT00024167 · 2002-04-01

Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate CancerNCT00003084 · 1997-12-01

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerNCT00002855 · 1996-08-01

Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung CancerNCT01134861 · 1994-07-01

Common conditions

Prostate Cancer3 AIDS-Related Hodgkin Lymphoma1 Ann Arbor Stage II Hodgkin Lymphoma1 Ann Arbor Stage IIA Hodgkin Lymphoma1 Ann Arbor Stage IIB Hodgkin Lymphoma1 Ann Arbor Stage III Hodgkin Lymphoma1 Ann Arbor Stage IIIA Hodgkin Lymphoma1 Ann Arbor Stage IIIB Hodgkin Lymphoma1 Ann Arbor Stage IV Hodgkin Lymphoma1 Ann Arbor Stage IVA Hodgkin Lymphoma1 Ann Arbor Stage IVB Hodgkin Lymphoma1 Classic Hodgkin Lymphoma1 Classical Hodgkin Lymphoma1 HIV Infection1 HIV-associated Hodgkin Lymphoma1 Lung Cancer1

Leading sponsors

M.D. Anderson Cancer Center3 Harlachinger Krebshilfe e.V.1 Merck Sharp & Dohme LLC1 National Cancer Institute (NCI)1 Radiation Therapy Oncology Group1

Trial status mix

COMPLETED5

TERMINATED1

UNKNOWN1

Phase mix

PHASE24

PHASE33

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.